Literature DB >> 17875699

The nuclear matrix protein, NRP/B, enhances Nrf2-mediated oxidative stress responses in breast cancer cells.

Seyha Seng1, Hava Karsenty Avraham, Shuxian Jiang, Suping Yang, Masayuki Sekine, Noam Kimelman, Huchun Li, Shalom Avraham.   

Abstract

The transcription factor NF-E2-related factor 2 (Nrf2) translocates into the nucleus and activates phase II genes encoding detoxification enzymes and antioxidant proteins, resulting in the protection of cells from oxidative insults. However, the involvement of Nrf2-mediated oxidative stress responses in breast cancer cells is largely unknown. Notably, during our study of the Nrf2 pathway in breast cancer cells, we observed that the nuclear matrix protein NRP/B was expressed and colocalized with Nrf2 in these cells, suggesting that NRP/B is involved in Nrf2-mediated oxidative stress responses. The expression level of NRP/B was variable in different breast cancer cells and breast cancer tissues, and was found to be localized in the nucleus. NRP/B expression was increased after exposure to the oxidative stress agent, hydrogen peroxide (H(2)O(2)), particularly in the highly aggressive MDA-MB-231 breast cancer cells. Association of NRP/B with Nrf2 in vitro and in vivo was observed in MDA-MB-231 breast cancer cells, and this association was up-regulated upon exposure to H(2)O(2), but not to sodium nitroprusside, SIN-1, and DETA-NO. NRP/B also enhanced Nrf2-mediated NAD(P)H:quinine oxidoreductase 1 promoter activity. Thus, this study reveals that NRP/B enhances oxidative stress responses in breast cancer cells via the Nrf2 pathway, identifying a novel role of nuclear matrix protein(s) in oxidative stress responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875699     DOI: 10.1158/0008-5472.CAN-06-3785

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Serum Proteomic Signatures of Male Breast Cancer.

Authors:  Eleni Zografos; Athanasios K Anagnostopoulos; Aggeliki Papadopoulou; Evangelia Legaki; Flora Zagouri; Evangelos Marinos; George T Tsangaris; Maria Gazouli
Journal:  Cancer Genomics Proteomics       Date:  2019 Mar-Apr       Impact factor: 4.069

2.  Differential proteomic analysis of pathway biomarkers in human breast cancer by integrated bioinformatics.

Authors:  Liu Fu-Jun; Jin Shao-Hua; Shen Xiao-Fang
Journal:  Oncol Lett       Date:  2012-08-24       Impact factor: 2.967

3.  Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.

Authors:  Salih Gencer; Anil Cebeci; Meliha Burcu Irmak-Yazicioglu
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

4.  Nuclear matrix protein (NRP/B) modulates the nuclear factor (Erythroid-derived 2)-related 2 (NRF2)-dependent oxidative stress response.

Authors:  Seyha Seng; Hava Karsenty Avraham; Gabriel Birrane; Shuxian Jiang; Shalom Avraham
Journal:  J Biol Chem       Date:  2010-05-28       Impact factor: 5.157

5.  Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level.

Authors:  Xiao-Jun Wang; Donna D Zhang
Journal:  PLoS One       Date:  2009-05-08       Impact factor: 3.240

6.  AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.

Authors:  Poornima Bhat-Nakshatri; Guohua Wang; Hitesh Appaiah; Nikhil Luktuke; Jason S Carroll; Tim R Geistlinger; Myles Brown; Sunil Badve; Yunlong Liu; Harikrishna Nakshatri
Journal:  Mol Cell Biol       Date:  2008-10-06       Impact factor: 4.272

7.  Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.

Authors:  Jie Feng; Lichuan Hong; Yonggang Wu; Chuzhong Li; Hong Wan; Guilin Li; Yilin Sun; Shenyuan Yu; Prashant Chittiboina; Blake Montgomery; Zhengping Zhuang; Yazhuo Zhang
Journal:  J Neurooncol       Date:  2014-06-11       Impact factor: 4.130

8.  The Nuclear Matrix Protein, NRP/B, Acts as a Transcriptional Repressor of E2F-mediated Transcriptional Activity.

Authors:  Jina Choi; Eun Sung Yang; Kiweon Cha; John Whang; Woo-Jung Choi; Shalom Avraham; Tae-Aug Kim
Journal:  J Cancer Prev       Date:  2014-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.